Ftse Mib
33.817,22
0,24%
DAX
17.931,19
0,14%
S&P 500
5.064,20
0,91%
NASDAQ
15.840,96
1,51%
Bitcoin
59.286,79
0,28%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ SurModics Inc (SRDX) SurModics Inc (SRDX) Notizie

SurModics Inc

SRDX
34,55
0,00 (0,00%)
03 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
01/5/202413:00BWSurmodics Reports Second Quarter of Fiscal Year 2024..
19/4/202413:00BWSurmodics to Report Second Quarter of Fiscal 2024 Financial..
27/2/202414:00BWSurmodics to Participate in Upcoming Investor Conferences in..
12/2/202422:22EDGAR2Form 8-K - Current report
12/2/202422:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202422:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202422:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202422:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202417:20EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07/2/202422:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202415:53EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01/2/202414:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/2/202413:00EDGAR2Form 8-K - Current report
01/2/202413:00BWSurmodics Reports First Quarter of Fiscal Year 2024..
29/1/202422:29EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
23/1/202423:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202413:30BWSurmodics Announces Successful Early Clinical Use of Pounce™..
16/1/202413:30BWSurmodics to Host Virtual Annual Meeting of Shareholders
03/1/202422:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/12/202322:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202322:05EDGAR2Form DEF 14A - Other definitive proxy statements
18/12/202322:05EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
06/12/202322:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202322:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202322:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202322:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202322:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202322:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202323:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202323:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202323:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202323:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202323:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202323:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202323:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202316:22EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
17/11/202322:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202322:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/11/202313:30BWSurmodics Announces TRANSCEND Trial 36-Month Data Presented..
14/11/202322:05BWSurmodics to Participate in the Piper Sandler Healthcare..
08/11/202313:30BWSurmodics Reports Fourth Quarter and Fiscal Year 2023..
08/11/202313:00EDGAR2Form 8-K - Current report
07/11/202313:30BWSurmodics Announces SWING Trial 24-Month Data to be..
31/10/202312:30BWSurmodics Announces Launch of Preside™ Medical Device..
10/10/202313:30BWSurmodics to Report Fourth Quarter and Fiscal 2023 Financial..
03/10/202322:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202323:05BWSurmodics to Participate in Upcoming Investor Conferences in..
02/8/202314:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/8/202313:31BWSurmodics Reports Third Quarter of Fiscal Year 2023..
Apertura: Min: Max:
Chiusura: 34,55

La tua Cronologia

NASDAQ
SRDX
SurModics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network